We showed that TRAIL, a typical proapoptotic peptide molecule (Sheridan et al, 1997; Almasan and Ashkenazi, 2003), is a potent inhibitor of angiogenesis-, tissue remodelling- or invasiveness-related factors in human glioblastoma cells. Here, TNFSF10 is linked to glioblastoma.